AU2019203814A1 — Compositions for respiratory delivery of active agents and associated methods and systems
Assigned to Pearl Therapeutics Inc · Expires 2019-06-20 · 7y expired
What this patent protects
Abstract Compositions, methods and systems are provided for pulmonary or nasal delivery of active agents via a metered dose inhaler. In one embodiment, the compositions include a suspension medium, active agent particles, and suspending 5 particles, in which the active agent part…
USPTO Abstract
Abstract Compositions, methods and systems are provided for pulmonary or nasal delivery of active agents via a metered dose inhaler. In one embodiment, the compositions include a suspension medium, active agent particles, and suspending 5 particles, in which the active agent particles and suspending particles form a co suspension within the suspension medium.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.